Roivant brings Pfiz­er vets Azoulay, Gul­fo in­to its C-suite; Aileron CEO Joseph Yanchik is out

→ Vivek Ra­maswamy has ush­ered two Pfiz­er vets in­to Roivant’s C-suite as he con­tin­ues to build his vi­sion for a Vant king­dom. New CMO Sa­lomon Azoulay most re­cent­ly held the same role at Pfiz­er Es­sen­tial Health, the busi­ness unit in charge of a slate of mar­ket­ed drugs. Adele Gul­fo, who’s now chief of com­mer­cial de­vel­op­ment, got her start launch­ing Lip­i­tor and used to run the busi­ness de­vel­op­ment for As­traZeneca be­fore join­ing Pfiz­er.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER